| |
| |
|
| Insider
Information: |
Sinha Vikas |
| Relationship: |
|
| City: |
Cheshire |
| State: |
CT |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
1,308,459 |
|
|
Indirect Shares
|
16,674,766 |
|
|
| Direct
Value |
$33,419,819 |
|
|
|
Indirect Value
|
$12,547,761 |
|
|
| Total
Shares |
17,983,225 |
|
|
| Total
Value |
$45,967,581 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
23
|
|
Stock
price went up :
|
0
|
8
|
| Stock
price went down : |
0
|
15
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -725.1%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Alexion Pharmaceuticals Inc |
ALXN |
EVP & CFO |
2016-08-08 |
178,463 |
2005-09-21 |
0 |
Premium* |
|
|
Allovir Inc |
ALVR |
|
2024-05-17 |
1,129,996 |
2024-05-17 |
16,674,766 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
145 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 5 of 6
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ALXN |
Alexion Pharmaceuticals I... |
SVP & CFO |
• – – |
2010-11-19 |
4 |
OE |
$13.79 |
$275,800 |
D/D |
20,000 |
93,281 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
EVP & CFO |
• – – |
2016-02-05 |
4 |
S |
$141.79 |
$280,404 |
D/D |
(1,954) |
175,752 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
EVP & CFO |
• – – |
2013-12-09 |
4 |
OE |
$17.65 |
$317,241 |
D/D |
17,974 |
152,295 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
EVP & CFO |
• – – |
2013-02-04 |
4 |
S |
$95.61 |
$333,692 |
D/D |
(3,483) |
308,155 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
EVP & CFO |
• – – |
2015-02-10 |
4 |
S |
$171.15 |
$339,733 |
D/D |
(1,985) |
162,708 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
SVP & CFO |
• – – |
2010-11-03 |
4 |
OE |
$13.79 |
$341,200 |
D/D |
24,000 |
73,281 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
EVP & CFO |
• – – |
2014-10-31 |
4 |
OE |
$17.65 |
$346,186 |
D/D |
19,307 |
182,077 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
SVP & CFO |
• – – |
2012-07-27 |
4 |
OE |
$11.92 |
$357,600 |
D/D |
30,000 |
345,388 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
SVP & CFO |
• – – |
2011-02-14 |
4 |
OE |
$13.79 |
$378,741 |
D/D |
25,002 |
106,480 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
SVP & CFO |
• – – |
2010-02-22 |
4 |
OE |
$13.79 |
$413,700 |
D/D |
30,000 |
84,307 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
EVP & CFO |
• – – |
2014-02-04 |
4 |
S |
$153.63 |
$414,801 |
D/D |
(2,700) |
129,775 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
EVP & CFO |
• – – |
2014-12-02 |
4 |
OE |
$17.98 |
$449,500 |
D/D |
25,000 |
187,770 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
SVP & CFO |
• – – |
2009-12-10 |
4 |
S |
$46.00 |
$460,000 |
D/D |
(10,000) |
49,707 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
EVP & CFO |
• – – |
2015-02-09 |
4 |
S |
$174.18 |
$470,810 |
D/D |
(2,703) |
164,693 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
EVP & CFO |
• – – |
2016-02-08 |
4 |
S |
$132.02 |
$535,316 |
D/D |
(3,890) |
171,862 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
EVP & CFO |
• – – |
2014-11-03 |
4 |
OE |
$17.96 |
$538,800 |
D/D |
30,000 |
192,770 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
EVP & CFO |
• – – |
2013-12-18 |
4 |
OE |
$17.65 |
$565,259 |
D/D |
32,026 |
166,347 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
EVP & CFO |
• – – |
2013-07-12 |
4 |
OE |
$11.92 |
$667,648 |
D/D |
50,000 |
362,655 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
SVP & CFO |
• – – |
2011-07-13 |
4 |
AS |
$52.53 |
$765,152 |
D/D |
(14,566) |
352,974 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
EVP & CFO |
• – – |
2013-10-28 |
4 |
OE |
$17.65 |
$882,500 |
D/D |
50,000 |
360,808 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
Sr VP and CFO |
• – – |
2008-08-01 |
4 |
AS |
$92.28 |
$923,520 |
D/D |
(10,000) |
31,149 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
EVP & CFO |
• – – |
2014-12-03 |
4 |
OE |
$17.98 |
$957,400 |
D/D |
50,000 |
212,770 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
SVP & CFO |
• – – |
2011-04-01 |
4 |
AS |
$100.00 |
$1,000,000 |
D/D |
(10,000) |
86,480 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
EVP & CFO |
• – – |
2014-12-18 |
4 |
AS |
$182.08 |
$1,000,165 |
D/D |
(5,493) |
157,277 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
SVP & CFO |
• – – |
2010-03-25 |
4 |
AS |
$55.00 |
$1,100,000 |
D/D |
(20,000) |
54,307 |
0 |
- |
|
145 Records found
|
|
Page 5 of 6 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
